Cyr William B. 4
4 · Freshpet, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Freshpet (FRPT) CEO William B. Cyr Exercises Options, Sells Shares
What Happened
William B. Cyr, CEO of Freshpet, exercised a total of 84,000 stock options on May 20, 2026 (exercise price $10.23) by paying approximately $859,321. At the same time he sold 47,582 of the resulting shares in open-market transactions for total gross proceeds of about $2,278,259 (sale prices ranged roughly $47.52–$47.92). The filing shows the option instruments were converted/ disposed as part of the exercise.
Key Details
- Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (timely).
- Options exercised: 84,000 shares at $10.23 each; total cash paid ≈ $859,321.
- Shares sold: 42,907 @ $47.92; 999 @ $47.52; 1,951 @ $47.52; 1,725 @ $47.52 — total 47,582 shares; total proceeds ≈ $2,278,259 (average ≈ $47.88).
- Derivative entries showing $0.00 reflect conversion of the option instruments into shares upon exercise.
- Footnotes: Sales were executed pursuant to a Rule 10b5-1 trading plan adopted Nov 5, 2025 (pre‑arranged sales). Options were granted under the Issuer’s 2014 Omnibus Incentive Plan and were fully vested as of Dec 31, 2020.
- Shares owned after the transactions are not specified in the text provided in this summary.
Context
This was a common executive action: exercising vested options and selling a portion of the resulting shares (effectively a cash‑raising step). Because the sales were part of a pre‑arranged 10b5‑1 plan, they were scheduled in advance rather than ad hoc market timing. The filing is informational and does not by itself indicate the CEO’s ongoing view of the company.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-05-20$10.23/sh+62,369$638,035→ 247,492 total - Sale
Common Stock
[F1]2026-05-20$47.92/sh−42,907$2,056,103→ 204,585 total - Exercise/Conversion
Common Stock
2026-05-20$10.23/sh+4,620$47,263→ 22,867 total(indirect: By Spouse) - Sale
Common Stock
[F1]2026-05-20$47.52/sh−999$47,472→ 21,868 total(indirect: By Spouse) - Exercise/Conversion
Common Stock
2026-05-20$10.23/sh+9,030$92,377→ 55,356 total(indirect: By Trust) - Sale
Common Stock
[F1]2026-05-20$47.52/sh−1,951$92,712→ 53,405 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2026-05-20$10.23/sh+7,981$81,646→ 51,458 total(indirect: By Trust) - Sale
Common Stock
[F1]2026-05-20$47.52/sh−1,725$81,972→ 49,733 total(indirect: By Trust) - Exercise/Conversion
Options to purchase common stock
[F2]2026-05-20−62,369→ 430,655 totalExercise: $10.23Exp: 2026-09-06→ Common Stock (62,369 underlying) - Exercise/Conversion
Options to purchase common stock
[F2]2026-05-20−4,620→ 31,900 total(indirect: By Spouse)Exercise: $10.23Exp: 2026-09-06→ Common Stock (4,620 underlying) - Exercise/Conversion
Options to purchase common stock
[F2]2026-05-20−9,030→ 62,350 total(indirect: By Trust)Exercise: $10.23Exp: 2026-09-06→ Common Stock (9,030 underlying) - Exercise/Conversion
Options to purchase common stock
[F2]2026-05-20−7,981→ 55,095 total(indirect: By Trust)Exercise: $10.23Exp: 2026-09-06→ Common Stock (7,981 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
- [F2]The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.